Medical device giant Medtronic buys telehealth company Cardiocom for $200M


Medtronic, a giant among medical device companies, is largely known for its expensive, implantable devices, like pacemakers and heart valves. But, in an announcement on Monday, the company said it plans to expand into chronic disease management with a $200 million all-cash acquisition of Cardiocom.

Founded in 1997, Cardiocom enables healthcare providers to remotely monitor patients with chronic conditions like diabetes and heart disease through products including home glucose monitors and interactive weight scale systems.

As new health laws increasingly fine hospitals for high patient readmission rates, Cardiocom puts Medtronic in a position to take advantage of the shifting tides and reach a broader set of patients. For example, according to the Wall Street Journal, Medtronic’s implantable heart-failure devices can cost more than $30,000 a pop, but only 13 percent of 7.5 million heart-failure patients get the device. The company said plans to start with a…

View original post 85 more words


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s